Blobel Friedhelm 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Aug 16, 2017
Insider Transaction Report
Form 4
Blobel Friedhelm
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2017-08-15−40,000→ 245,000 total→ Common Stock (40,000 underlying) - Tax Payment
Common Stock
2017-08-15$11.05/sh−20,872$230,636→ 141,337 total - Exercise/Conversion
Common Stock
2017-08-15+40,000→ 162,209 total
Footnotes (4)
- [F1]Shares disposed represent shares withheld to cover withholding tax obligations in connection with the vesting of Restricted Stock Units.
- [F2]Granted under the Issuer's 2015 Equity Incentive Plan.
- [F3]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F4]Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017.